Effect of Salt Substitution on Cardiac Structure and ECG Parameters in Middle-aged and Elderly Hypertensive Patients

Li Che1, Ying Zhang2, Xia Chen3

  • 1Department of Cardiology, Central Hospital of Dalian University of Technology, 116033 Dalian, Liaoning, China.

PubMed

Insights

Salt substitution (SS) significantly improves cardiac structure and electrocardiogram (ECG) parameters in hypertensive patients. This intervention reduces left atrial diameter (LAD) and left ventricular mass (LVM), offering potential cardiac risk management benefits.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Cardiovascular Research

Background:

  • Salt substitution (SS) is known to reduce blood pressure (BP).
  • The effects of SS on cardiac structure and ECG parameters are not well understood.
  • Hypertension poses significant cardiovascular risks.

Purpose of the Study:

  • To evaluate the impact of salt substitution on cardiac structure using ultrasonic cardiogram (UCG).
  • To assess the effects of salt substitution on electrocardiogram (ECG) parameters.
  • To investigate the role of SS in managing cardiac risks in hypertensive individuals.

Main Methods:

  • A 12-month, multi-center, randomized, double-blind study.
  • Involved 352 hypertensive patients aged 50-70 years.
  • Compared normal salt (NS) with salt substitution (SS) groups, measuring BP, UCG, and ECG parameters.

Main Results:

  • Salt substitution significantly reduced systolic and diastolic BP compared to normal salt.
  • SS led to significant reductions in left atrial diameter (LAD) and left ventricular mass (LVM).
  • Improvements were observed in UCG parameters, including QT dispersion (QTd), Tp-e, and Tp-e/QT.

Conclusions:

  • Salt substitution effectively improves cardiac structure (LAD, LVM) in hypertensive patients.
  • SS positively impacts key ECG parameters (QTd, Tp-e, Tp-e/QT).
  • SS represents a promising intervention for mitigating cardiac risks associated with hypertension.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
385
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
340
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
316
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.9K
Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
455
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
2